Elena De Mattia

20PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 10, 2026
DPYD and UGT1A1 Genotype-Based Dosing for Fluoropyrimidines and Irinotecan Chemotherapy: Variant-Specific Impact on Treatment Intensity and Toxicity.

|Sep 25, 2025
Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity - A secondary analysis of the PREPARE trial.

Elena De Mattia, Yoomi Park, Elena Peruzzi

|Jul 24, 2024
Somatic pharmacogenomics in the treatment prognosis of locally advanced rectal cancer patients: a narrative review of the literature.

Noemi Milan, Federico Navarria, Erika Cecchin

|May 27, 2023
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.

Maurizio Polano, Luca Bedon, Michele Dal Bo

|Mar 11, 2023
Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis.

Elena De Mattia, Jerry Polesel, Silvia Mezzalira

|Feb 25, 2023
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.

Chiara Dalle Fratte, Jerry Polesel, Sara Gagno

Pageof 4

Frequent Collaborators

16 joint publications

Erika Cecchin

14 joint publications

Giuseppe Toffoli

7 joint publications

Rossana Roncato

7 joint publications

Jerry Polesel